Patents by Inventor Daniel R. Goldberg

Daniel R. Goldberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12051239
    Abstract: Tracking an item of interest through an environment is described. Tracking the item of interest through the environment is accomplished using passive optical tracking where an item is identified in an image of the environment using image processing and various locations of the item are tracked through the environment. When a user wants to know an item's location, a location image is projected onto the location of the item to allow a user view a current location of the item.
    Type: Grant
    Filed: August 11, 2020
    Date of Patent: July 30, 2024
    Assignee: Disney Enterprises, Inc.
    Inventors: Evan M. Goldberg, Mark R. Mine, Matthew Deuel, Daniel L. Baker, Dane M. Coffey, Steven M. Chapman
  • Patent number: 11759462
    Abstract: The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.
    Type: Grant
    Filed: March 15, 2021
    Date of Patent: September 19, 2023
    Inventors: Stéphane De Lombaert, Daniel R. Goldberg, Kenneth Brameld, Eric Brian Sjogren, Andrew Scribner
  • Patent number: 11708365
    Abstract: The present disclosure is directed to intermediates and salts thereof useful for the preparation of spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1). Processes of preparing the intermediates, salts, and TPH inhibitors are also provided.
    Type: Grant
    Filed: January 14, 2021
    Date of Patent: July 25, 2023
    Inventors: Stéphane De Lombaert, Daniel R. Goldberg
  • Publication number: 20230078209
    Abstract: Disclosed herein is a medical device. The medical device includes a blade tube section, a solenoid, and a mechanical arrangement. The blade tube section includes an outer blade tube, an inner blade tube, and a cutting window at a distal end of the blade tube section. The solenoid is offset from a central axis of the blade tube section. The mechanical arrangement is between the inner blade tube and the solenoid.
    Type: Application
    Filed: November 9, 2022
    Publication date: March 16, 2023
    Inventors: Kevin Cooper Edwards, Ahmad Alsaffar, Joel Andrew Willhite, David C. Chruch, Daniel R. Goldberg
  • Publication number: 20220249249
    Abstract: Systems, methods and devices for providing orthopedic implant augments are provided which have fastener locking mechanisms. The augments include a surface for mating with an implant component and a surface for interfacing with a patient's bone. The fastener locking mechanisms are aligned such that the augment may be locked in a variety of orientations while maintaining close contact with both an implant and a patient's bone. The alignment of the locking mechanisms provides variability and adjustability to the augment to address a variety of bone anatomies and requirements.
    Type: Application
    Filed: April 28, 2022
    Publication date: August 11, 2022
    Applicant: Smith & Nephew, Inc.
    Inventors: Jeffrey J. Shea, Nathaniel M. Quinn, Daniel R. Goldberg
  • Publication number: 20220225864
    Abstract: An endoscope sheath comprising: a proximal end; a distal end having a distal end region; a surface extending between and connecting the proximal end and the distal end; and a plurality of positioning devices located along the surface; wherein the sheath is configured to: (1) receive all or a portion of an endoscope having a cylindrical end and (2) provide a conduit for communicating fluid between the proximal end of the sheath and the distal end of the sheath when the endoscope is inserted inside the sheath; and wherein the distal end region of the sheath includes the plurality of positioning devices that secure the cylindrical end of the endoscope against a portion of an inner wall of the surface extending between the proximal end and the distal end so that a fluid barrier is created between the cylindrical end of the endoscope and the inner wall.
    Type: Application
    Filed: February 2, 2022
    Publication date: July 21, 2022
    Inventors: Gregory S. Konstorum, Ming J. Cheng, Daniel R. Goldberg
  • Patent number: 11344432
    Abstract: Systems, methods and devices for providing orthopedic implant augments are provided which have fastener locking mechanisms. The augments include a surface for mating with an implant component and a surface for interfacing with a patient's bone. The fastener locking mechanisms are aligned such that the augment may be locked in a variety of orientations while maintaining close contact with both an implant and a patient's bone. The alignment of the locking mechanisms provides variability and adjustability to the augment to address a variety of bone anatomies and requirements.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: May 31, 2022
    Assignee: Smith & Nephew, Inc.
    Inventors: Jeffrey J. Shea, Nathaniel M. Quinn, Daniel R. Goldberg
  • Patent number: 11266303
    Abstract: An endoscope sheath configured to receive a portion of an endoscope can include a tubular member and a positioning device located on the tubular member. The positioning device can include a crimp that is configured to prevent distal movement of a portion of the endoscope relative to the tubular member.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: March 8, 2022
    Assignee: Gyrus Acmi, Inc.
    Inventors: Gregory S. Konstorum, Ming J. Cheng, Daniel R. Goldberg
  • Publication number: 20210393412
    Abstract: Systems, devices, and methods for providing orthopedic augments having recessed pockets that receive a fixation material. The orthopedic augments include an outer surface that interfaces with a patient's tissue or bone, an inner surface that interfaces with an implant and having a recessed pocket configured to receive a fixation material, a rim around at least a portion of the recessed pocket, and a port in the rim, wherein the recessed pocket extends along the inner surface in at least a lateral direction from the port.
    Type: Application
    Filed: September 2, 2021
    Publication date: December 23, 2021
    Applicant: Smith & Nephew, Inc.
    Inventors: Jeffrey J. Shea, Daniel R. Goldberg, Nathaniel M. Quinn, Stanley Tsai
  • Patent number: 11135067
    Abstract: Systems, devices and methods for providing orthopedic augments having recessed pockets that receive a fixation material. The orthopedic augments include an outer surface that interfaces with a patient's tissue or bone, an inner surface that interfaces with an implant and having a recessed pocket configured to receive a fixation material, a rim around at least a portion of the recessed pocket, and a port in the rim, wherein the recessed pocket extends along the inner surface in at least a lateral direction from the port.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: October 5, 2021
    Assignee: Smith & Nephew, Inc.
    Inventors: Jeffrey J. Shea, Daniel R. Goldberg, Nathaniel M. Quinn, Stanley Tsai
  • Publication number: 20210205305
    Abstract: The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.
    Type: Application
    Filed: March 15, 2021
    Publication date: July 8, 2021
    Applicant: Altavant Sciences GmbH
    Inventors: Stéphane De Lombaert, Daniel R. Goldberg, Kenneth Brameld, Eric Brian Sjogren, Andrew Scribner
  • Publication number: 20210139481
    Abstract: The present disclosure is directed to intermediates and salts thereof useful for the preparation of spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1). Processes of preparing the intermediates, salts, and TPH inhibitors are also provided.
    Type: Application
    Filed: January 14, 2021
    Publication date: May 13, 2021
    Applicant: ALTAVANT SCIENCES GmbH
    Inventors: STÉPHANE DE LOMBAERT, DANIEL R. GOLDBERG
  • Patent number: 10946018
    Abstract: The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: March 16, 2021
    Assignee: Roivant Sciences GmbH
    Inventors: Stéphane De Lombaert, Daniel R. Goldberg, Kenneth Brameld, Eric Brian Sjogren, Andrew Scribner
  • Patent number: 10799097
    Abstract: A system comprising: (a) a sheath configured to receive all or a portion of an endoscope; (b) an irrigation line connecting the sheath to an irrigation source; (c) a suction line connecting the sheath to a suction source; and (d) a control module located between the sheath, and the irrigation source and the suction source and controls flow of irrigation fluid from the irrigation source to the sheath and movement of suction between the suction source and the sheath; wherein the irrigation source is connected to a resilient reservoir that is located within the control module and movement of the control module compresses the resilient reservoir moving irrigation fluid from the resilient reservoir to the sheath so that the irrigation fluid assists in cleaning the endoscope, and wherein the control module includes a valve and compression of the resilient reservoir initiates movement of the valve so that the valve opens and suction from the suction line is applied to the sheath.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: October 13, 2020
    Assignee: Gyrus Acmi, Inc.
    Inventors: Ming J. Cheng, David C. Church, Daniel R. Goldberg, Gregory S. Konstorum, J. Andrew Willhite
  • Publication number: 20200237760
    Abstract: The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.
    Type: Application
    Filed: April 16, 2020
    Publication date: July 30, 2020
    Applicant: Roivant Sciences GmbH
    Inventors: Stéphane De Lombaert, Daniel R. Goldberg, Kenneth Brameld, Eric Brian Sjogren, Andrew Scribner
  • Patent number: 10710948
    Abstract: The present invention relates to processes for the preparation of (R)-1-(5-chloro-[1,1?-biphenyl]-2-yl)-2,2,2-trifluoroethanol, 1-(5-chloro-[1,1?-biphenyl]-2-yl)-2,2,2-trifluoroethanone, and intermediates thereof, which are useful in the preparation of inhibitors of TPH1 for the treatment of, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, low bone mass diseases, serotonin syndrome, and cancer.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: July 14, 2020
    Assignee: Roivant Sciences GmbH
    Inventors: Stéphane De Lombaert, Daniel R. Goldberg
  • Patent number: 10660893
    Abstract: The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: May 26, 2020
    Assignee: ROIVANT SCIENCES, GmbH
    Inventors: Stéphane De Lombaert, Daniel R. Goldberg, Kenneth Brameld, Eric Brian Sjogren, Andrew Scribner
  • Publication number: 20200071316
    Abstract: The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.
    Type: Application
    Filed: August 9, 2019
    Publication date: March 5, 2020
    Inventors: Daniel R. Goldberg, Peter Probst, Kristin M. Bedard
  • Publication number: 20200055871
    Abstract: The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.
    Type: Application
    Filed: August 9, 2019
    Publication date: February 20, 2020
    Inventors: Daniel R. Goldberg, Peter Probst, Kristin M. Bedard
  • Publication number: 20200015665
    Abstract: An endoscope sheath comprising: a proximal end; a distal end having a distal end region; a surface extending between and connecting the proximal end and the distal end; and a plurality of positioning devices located along the surface; wherein the sheath is configured to: (1) receive all or a portion of an endoscope having a cylindrical end and (2) provide a conduit for communicating fluid between the proximal end of the sheath and the distal end of the sheath when the endoscope is inserted inside the sheath; and wherein the distal end region of the sheath includes the plurality of positioning devices that secure the cylindrical end of the endoscope against a portion of an inner wall of the surface extending between the proximal end and the distal end so that a fluid barrier is created between the cylindrical end of the endoscope and the inner wall.
    Type: Application
    Filed: September 24, 2019
    Publication date: January 16, 2020
    Inventors: Gregory S. Konstorum, Ming J. Cheng, Daniel R. Goldberg